Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$6.64 0.09 (1.37%)
2/9/2010 4:00 PM

PDL BioPharma, Inc. (PDLI)

CAPS Rating:
****

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PDLI

Add Stock to Watchlist

What the Community Thinks

Total Members

668 Outperforms
35 Underperforms
 

All-Stars

218 Outperforms
6 Underperforms
 

Wall Street

5 Outperforms
0 Underperforms
 

Members bullish on PDLI are also bullish on:

Members bearish on PDLI are also bearish on:

Ticker Tags

Biotechnology (220), Optionable (25), Healthcare (711), Income (1401), Small Cap (1645)
Suggest a tag

PDL BioPharma, Inc. At A Glance

Current Price: $6.64
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $6.55
Daily Range: $6.60 - $6.72
52-Week Range: $5.20 - $9.32
Volume: 1,600,924
Market Cap: $794.62M
P/E Ratio: 3.60
Compare Our Special Broker Offers!

Stock Trends

PDLI VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

PDL BioPharma, Inc. (PDLI)

Avatar marketprofile01 (45.16) Submitted: 12/23/09 4:59 PM

If we assume initial earnings of $68.4M grow at a rate of 26.00%, and we discount those future earnings at a rate of 15.00%, we arrive at a net present value for the company's next 10 years of earnings of undefined. To account for potential earnings beyond the 10th year, we estimate a growth rate of...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

PDL BioPharma, Inc. (PDLI)

Avatar tutaemeia (95.03) Submitted: 12/20/08 1:57 PM

No way this guys will have good times soon. The fundamentals talk by themselves:

Who will by a company with a P/B of 16x, have a ROE in the last 5y of -11, a P/S of 3,63x? Maybe you are looking for the 62,87% of Dividend Yield (Trailing 12mo.). But remember, with a company do not have pro...More

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 101 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (PDLI)

Avatar totallyoblivious (23.20) Submitted: 2/09/10 5:15 PM : Outperform Start Price: $6.62 PDLI Score: 0.75

Bought into this today based heavily on the dividends they're paying out this year. They also seem to have a nice revenue stream from royalties which seem secure for the next ~4 years. I'll be watching them very closely, however, in about 2 years to see if they've found a new source of revenue, and if nothing looks promising, it'll be time to sell.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDLI)

Avatar rnobrien (55.67) Submitted: 1/24/10 11:15 PM : Outperform Start Price: $6.62 PDLI Score: 3.02

This stock attracted to me due to the fact that there is a built-in revenue stream from royalties from several different approved drugs and manufacturers (Biogen-Idec, Lilly, Genentech/Roche), with more in the pipeline. My only concern is that with the patent expiration date only 4 years away, this is a medium-term investment.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDLI)

Avatar HoosierJoe100 (< 20) Submitted: 1/23/10 7:57 PM : Outperform Start Price: $6.62 PDLI Score: 3.02

Promising R&D pipeline.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDLI)

Avatar getrichdietrying (80.56) Submitted: 1/15/10 11:58 AM : Outperform Start Price: $6.75 PDLI Score: 4.00

Everyone says buys all sites.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDLI)

Avatar mrbill6 (< 20) Submitted: 1/15/10 8:00 AM : Outperform Start Price: $6.89 PDLI Score: 2.92

msn:9 (up from a 7), navallier:B, potential dividend

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 101 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJMP 71.98 03/03/09 Outperform NS $4.50+47.50%+54.78%-7.28
TrackWedbush 66.12 03/03/09 Outperform NS $4.57+45.22%+52.49%-7.27
TrackEveillard 93.31 09/30/07 Outperform NS $7.71-13.90%-26.38%+12.48 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer < 20 03/26/07 Outperform 3W $7.28-8.79%-20.84%+12.05
TrackLazardCapit < 20 11/06/06 Outperform NS $7.15-7.20%-16.91%+9.72

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD04 62ms